Epidermal stem and transit amplifying cells

A single skin sample contains a hidden hierarchy of cells: a small pool of stem cells that renew the epidermis, and a larger population of "transit amplifying" cells that divide a few times before maturing. This lab is mapping the molecular differences between these two cell types—what proteins they make, which genes are active, and what happens when a stem cell receives the signal to start dividing. The problem is that we still do not fully understand what distinguishes a stem cell from its more committed offspring. Without that knowledge, growing skin grafts in the lab remains partly guesswork, and we lack clear molecular targets for drugs aimed at cancers that arise from uncontrolled stem cell division. If this work succeeds, it could improve the quality of cultured skin grafts used to treat severe burns and chronic wounds. It may also reveal molecules and mechanisms that operate in stem cells elsewhere in the body—in muscle, brain, or bone marrow—because the same fundamental controls are likely shared. And by identifying the molecular switches that trigger stem cell division, the research could point toward new targets for anti-cancer drugs. This is fundamental science with clear, practical endpoints in regenerative medicine and oncology.